Stock listing
TSXV:SHRX Sharp Therapeutics Corp. Stock
Home listing (TSXV) of Sharp Therapeutics Corp.
Follow Sharp Therapeutics Corp. into a list and get an email when it puts out news.
Share price · TSXV:SHRX
$1.37 CAD 0.00 (0.0%)
Close on Oct 13, 2026 · Data provided by Twelve Data
- Ticker
- TSXV:SHRX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- TSXV
- Currency
- CAD
What changed lately
Latest news release · Aug 28, 2026
Sharp Therapeutics Corp. Reports First Half 2026 Results and Development Update
Latest news
Financings
Private placement of common shares
Jul 29, 2026 · US$969,254
Closed: C$1.36M raised · C$0.91 a share
Buyers: Newlin Investment Company 1, LLC (subscribed for US$200,000.45)
Insiders: Newlin Investment Company 1, LLC, wholly owned by director and Chairman William R. Newlin, subscribed for US$200,000.45
Use of proceeds: General working capital purposes
Conditional share purchase commitment
Jul 15, 2026
Cancelled: up to US$10M
Buyers: STX Partners
Sharp Therapeutics Corp. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 28 in all · newest Aug 28, 2026 · oldest 2024
Where Sharp Therapeutics Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSXV:SHRX · Home listing · This page | TSXV | Canada | CAD |
| OTC:SHRXF | OTC | United States | USD |
| Cboe Canada:SHRX | Cboe Canada | Canada | CAD |
Log in to ask 6ix AI your own questions about Sharp Therapeutics Corp.